Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

PTP CD45 Inhibitor

Base Information Edit
  • Chemical Name:PTP CD45 Inhibitor
  • CAS No.:345630-40-2
  • Molecular Formula:C19H17NO3
  • Molecular Weight:307.34
  • Hs Code.:
  • European Community (EC) Number:803-514-0
  • Nikkaji Number:J1.562.949E
  • Pharos Ligand ID:51VD7DT93JXB
  • ChEMBL ID:CHEMBL51314
  • Mol file:345630-40-2.mol
PTP CD45 Inhibitor

Synonyms:SF1670

Suppliers and Price of PTP CD45 Inhibitor
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • SF1670
  • 50mg
  • $ 550.00
  • Tocris
  • SF1670 ≥98%(HPLC)
  • 50
  • $ 668.00
  • Tocris
  • SF1670 ≥98%(HPLC)
  • 10
  • $ 159.00
  • Sigma-Aldrich
  • SF1670 ≥98% (HPLC)
  • 5mg
  • $ 204.00
  • Sigma-Aldrich
  • PTP CD45 Inhibitor
  • 5mg
  • $ 200.00
  • Sigma-Aldrich
  • SF1670 ≥98% (HPLC)
  • 25mg
  • $ 817.00
  • DC Chemicals
  • SF1670 >98%
  • 250 mg
  • $ 900.00
  • CSNpharm
  • SF1670
  • 1mg
  • $ 51.00
  • CSNpharm
  • SF1670
  • 10mg
  • $ 133.00
  • CSNpharm
  • SF1670
  • 100mg
  • $ 898.00
Total 12 raw suppliers
Chemical Property of PTP CD45 Inhibitor Edit
Chemical Property:
  • Boiling Point:554.1±29.0 °C(Predicted) 
  • PKA:14.31±0.20(Predicted) 
  • PSA:66.73000 
  • Density:1.271±0.06 g/cm3(Predicted) 
  • LogP:4.36670 
  • Storage Temp.:2-8°C 
  • Solubility.:DMSO: soluble10mg/mL, clear 
  • XLogP3:3.1
  • Hydrogen Bond Donor Count:1
  • Hydrogen Bond Acceptor Count:3
  • Rotatable Bond Count:2
  • Exact Mass:307.12084340
  • Heavy Atom Count:23
  • Complexity:519
Purity/Quality:

98%,99%, *data from raw suppliers

SF1670 *data from reagent suppliers

Safty Information:
  • Pictogram(s): Xi 
  • Hazard Codes:Xi 
  • Statements: 36/37/38 
  • Safety Statements: 26 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC(C)(C)C(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C(=O)C2=O
  • Uses SF1670 is used in the methods and compositions for treating tumor or cancer by administering to a subject a PTEN inhibitor and chemotherapeutic agents, immume dysregulation in patients with PTEN harmartoma tumor syndrome and analysis of FOXP3 regulatory T cells. SF1670 has been used:To study the effect of microRNA-30a on PTEN (phosphatase and tensin homologue deleted on chromosome 10 ) expression regulation.To study the formation of autophagosomes, induced by EGF (Epidermal growth factor) - dependent PTEN expression.To study the role of PTEN in the regulation of autophagy induction in human normal endometrial stromal cells.
Post RFQ for Price